127 related articles for article (PubMed ID: 30775185)
1. Discordant financial conflicts of interest disclosures between clinical trial conference abstract and subsequent publication.
Weiss GJ; Davis RB
PeerJ; 2019; 7():e6423. PubMed ID: 30775185
[TBL] [Abstract][Full Text] [Related]
2. Dependability of results in conference abstracts of randomized controlled trials in ophthalmology and author financial conflicts of interest as a factor associated with full publication.
Saldanha IJ; Scherer RW; Rodriguez-Barraquer I; Jampel HD; Dickersin K
Trials; 2016 Apr; 17(1):213. PubMed ID: 27113767
[TBL] [Abstract][Full Text] [Related]
3. Industry compensation and self-reported financial conflicts of interest among authors of highly cited peripheral artery disease studies.
Bellomo TR; Hwang C; Spector-Bagdady K; Stanley JC; Corriere MA
J Vasc Surg; 2020 Aug; 72(2):673-684. PubMed ID: 31980241
[TBL] [Abstract][Full Text] [Related]
4. Financial Conflicts of Interest Change After a High-Impact Clinical Trial Publication in Oncology.
Cambridge CL; Gatof ES; Weiss GJ; Davis RB
J Patient Cent Res Rev; 2020; 7(3):249-254. PubMed ID: 32760756
[TBL] [Abstract][Full Text] [Related]
5. Authors of clinical trials seldom reported details when declaring their individual and institutional financial conflicts of interest: a cross-sectional survey.
Hakoum MB; Noureldine H; Habib JR; Abou-Jaoude EA; Raslan R; Jouni N; Hasbani DJ; Lopes LC; Guyatt G; Akl EA
J Clin Epidemiol; 2020 Nov; 127():49-58. PubMed ID: 32512186
[TBL] [Abstract][Full Text] [Related]
6. Do Editorialists With Industry-Related Conflicts of Interest Write Unduly Favorable Editorials for Cancer Drugs in Top Journals?
Sharma S; Booth CM; Eisenhauer EA; Gyawali B
J Natl Compr Canc Netw; 2021 Jul; 19(11):1258-1263. PubMed ID: 34325401
[TBL] [Abstract][Full Text] [Related]
7. Authors' self-declared financial conflicts of interest do not impact the results of major cardiovascular trials.
Aneja A; Esquitin R; Shah K; Iyengar R; Nisenbaum R; Melo M; Matthewkutty S; Sethi SS; Mamdani M; Farkouh ME
J Am Coll Cardiol; 2013 Mar; 61(11):1137-43. PubMed ID: 23395075
[TBL] [Abstract][Full Text] [Related]
8. Reporting of financial conflicts of interest in clinical practice guidelines: a case study analysis of guidelines from the Canadian Medical Association Infobase.
Shnier A; Lexchin J; Romero M; Brown K
BMC Health Serv Res; 2016 Aug; 16(a):383. PubMed ID: 27528247
[TBL] [Abstract][Full Text] [Related]
9. Financial Conflicts of Interest in Clinical Practice Guidelines: A Systematic Review.
Tabatabavakili S; Khan R; Scaffidi MA; Gimpaya N; Lightfoot D; Grover SC
Mayo Clin Proc Innov Qual Outcomes; 2021 Apr; 5(2):466-475. PubMed ID: 33997642
[TBL] [Abstract][Full Text] [Related]
10. Financial relationships with industry among guideline authors for the management of acute ischemic stroke.
Niforatos JD; Pescatore RM
Am J Emerg Med; 2019 May; 37(5):921-923. PubMed ID: 30704949
[TBL] [Abstract][Full Text] [Related]
11. Financial Conflicts of Interest in Inflammatory Bowel Disease Guidelines.
Grindal AW; Khan R; Scaffidi MA; Rumman A; Grover SC
Inflamm Bowel Dis; 2019 Mar; 25(4):642-645. PubMed ID: 30295831
[TBL] [Abstract][Full Text] [Related]
12. Oral presentation to publication: publication rates of abstract presentations across two pediatric neurosurgical meetings.
Bonfield CM; Pellegrino R; Berkman J; Naftel RP; Shannon CN; Wellons JC
J Neurosurg Pediatr; 2018 Jun; 21(6):650-654. PubMed ID: 29521604
[TBL] [Abstract][Full Text] [Related]
13. A new method for scoring financial conflicts of interest.
Maharaj SV
Int J Occup Environ Health; 2015; 21(1):49-52. PubMed ID: 25633929
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of post-publication Financial Conflict of Interest corrections in medical research: A secondary analysis of pharmaceutical company payments to the authors of the CREATE-X trial report in the New England Journal of Medicine.
Ozaki A; Saito H; Sawano T; Shimada Y; Tanimoto T
Bioethics; 2021 Sep; 35(7):704-713. PubMed ID: 34137057
[TBL] [Abstract][Full Text] [Related]
15. Conversion of Skeletal Society of Radiology annual meeting abstracts to publications in 2010-2015.
Tritz D; Bautista L; Scott J; Vassar M
PeerJ; 2018; 6():e5817. PubMed ID: 30364493
[TBL] [Abstract][Full Text] [Related]
16. Discrepancies between author- and industry-reported disclosures of financial relationships at an annual gynecologic oncology research meeting.
Guo XM; Cowan M; Folsom S; Ehimiaghe E; Persenaire C; Barber EL; Tanner EJ
Gynecol Oncol; 2021 Jan; 160(1):260-264. PubMed ID: 33187761
[TBL] [Abstract][Full Text] [Related]
17. Conversion of Society for Maternal-Fetal Medicine abstract presentations to manuscript publications.
Manuck TA; Barbour K; Janicki L; Blackwell SC; Berghella V
Am J Obstet Gynecol; 2015 Sep; 213(3):405.e1-6. PubMed ID: 25981850
[TBL] [Abstract][Full Text] [Related]
18. Correlation between financial relationships with commercial interests and research prominence at an oncology meeting.
Moy B; Bradbury AR; Helft PR; Egleston BL; Sheikh-Salah M; Peppercorn J
J Clin Oncol; 2013 Jul; 31(21):2678-84. PubMed ID: 23775973
[TBL] [Abstract][Full Text] [Related]
19. Consistency of phase III clinical trial abstracts presented at an annual meeting of the American Society of Clinical Oncology compared with their subsequent full-text publications.
Tam VC; Hotte SJ
J Clin Oncol; 2008 May; 26(13):2205-11. PubMed ID: 18445846
[TBL] [Abstract][Full Text] [Related]
20. Publication rate of abstracts presented at the 2010 Canadian Ophthalmological Society Annual Meeting.
Basilious A; Benavides Vargas AM; Buys YM
Can J Ophthalmol; 2017 Aug; 52(4):343-348. PubMed ID: 28774514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
